Join Qinecsa at DIA Global Pharmacovigilance and Risk Management Strategies Conference
Qinecsa’s team of experts is looking forward to connecting with you at the DIA Global Pharmacovigilance and Risk Management Strategies Conference 2024. DIA’s Global Pharmacovigilance and Risk Management Strategies Conference is developed by regulators and industry experts to discuss the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety professionals. Visit […]
Qinecsa appoints John Freeman JD, M.Sc., B.Sc. to the Board of Directors
Announcement – 14th December 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of John Freeman JD, M.Sc., B.Sc. as Non-executive Director. With a background in Clinical Pharmacology and Law, John has held prominent global leadership roles in pharmacovigilance and risk management. He has worked in the field of pharmacovigilance since […]
Launching the next-generation Literature Management solution
Announcement – Qinecsa Solutions Launches Next-Generation Literature Management Solution in Collaboration with AAICO, Revolutionizing Pharmacovigilance with AI London, December 13, 2023 – Qinecsa Solutions, experts in technology-driven end-to-end pharmacovigilance solutions, proudly announces the launch of its latest literature management solution in partnership with The Applied AI Company (AAICO). This strategic union combines Qinecsa’s medical […]
Join Qinecsa at J.P. Morgan Healthcare Conference 2024
Qinecsa is on a mission to drive positive change in the pharmacovigilance industry. As we enter a new year with exciting plans to continue advancing pharmacovigilance solutions, we look forward to engaging with industry leaders and investors at the forefront of healthcare innovation. Meet John Gillie, Qinecsa CEO at the event to explore the potential […]
Qinecsa appoints Arthur Shih as General Counsel
6 November 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Arthur Shih as General Counsel. With over 25 years in private practice and in-house leadership roles, Arthur brings extensive international legal and commercial experience to support the execution of Qinecsa’s future growth strategy. “Qinecsa is a market-leader […]
Introducing the Qinecsa PV Insights Network: Connecting peers for practical drug safety solutions
Empowering leaders in small pharma and biotech with responsibility for drug safety We are thrilled to announce the launch of the Qinecsa PV Insights Network, an initiative designed specifically for pharmacovigilance (PV) leaders in small pharma and biotech companies who bear the critical responsibility of drug safety. Following the overwhelming response to a series of […]
Join Qinecsa at World Drug Safety Congress US, 18-19 October, Boston
We are thrilled to be heading back to Boston to attend the World Drug Safety Congress US, which brings together 1000+ top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety. Our team of experts is looking forward to being part of the discussions regarding strategies in […]
Join Qinecsa at World Drug Safety Congress Europe, 4-5 October, Amsterdam
Our team is delighted to once again be attending the World Drug Safety Congress Europe, which brings together 1500+ key thought leaders to explore key challenges in pharmacovigilance. From exploring the use of big data and AI in pharmacovigilance, examining benefit-risk management strategies and patient-centric approaches, drug safety is at the forefront of innovative technologies […]
Fit-for-future sourcing for pharmacovigilance: Embracing Change for Success
Author: Humaira Qureshi, President of Qinecsa Solutions The pharmacovigilance industry is in an unprecedented era of change. PV teams are experiencing year-on-year increases in case volumes, driven in part by increased awareness and reporting by patients. Regulatory agencies are embracing the opportunities provided by innovation and technology, and the rise in methods and formats to […]
Join Qinecsa at 32nd Pharmacovigilance 2023, 26-27 April, Boston
Join Qinecsa at 32nd Pharmacovigilance 2023 to discuss the latest developments in pharmacovigilance, drug safety & risk management.Our President, Humaira Qureshi, will present ‘Fit for future sourcing for pharmacovigilance’ where she will discuss the drivers for change in the pharmacovigilance industry, the challenges faced by PV teams, and how traditional models of delivery need to […]
